A company called Benzinga wrote an article that says people are not very happy or optimistic about cannabis businesses right now. The prices of some cannabis companies' stocks have gone down a lot, and they don't expect them to go up soon. But the article also talks about a person named Michael Berger who knows a lot about cannabis stocks and has found some good ones that could make people money in the future. He has already helped some people make good money from these stocks this year, and he is looking for more opportunities to do so. Read from source...
- The title of the article suggests a bearish sentiment across the cannabis space, but the body of the text does not provide any evidence or analysis to support this claim. It is a clickbait headline that tries to attract readers without delivering any substance or insight.
- The author relies on outdated and irrelevant data (January 18, 2024) to make his points, which makes the article seem unprofessional and careless. He does not explain why he chose these specific dates or what they represent in terms of market trends or performance.
- The author mentions several cannabis stocks (Aurora Cannabis, Blueberries Medical, Corbus Pharmaceuticals, Green Thumb Industries, Village Farms Intl) and their closing prices, but he does not provide any context or comparison to the previous days or weeks. He also does not mention how these stocks are related to the overall cannabis space or the main themes of the article (bearish sentiment, growth opportunities, etc.).
- The author promotes his own service (PotProfits) as an expert and a reliable source of information, but he does not disclose any credentials, track record, or methodology. He also uses vague and exaggerated terms like "smoking-hot gains" and "juiciest potential double-digit opportunities" to persuade readers to subscribe without providing any proof or details.
- The author tries to create a sense of urgency and scarcity by saying that he is about to release his next picks, but he does not specify when, how, or why readers should act on this information. He also does not mention any risks or limitations associated with his service or recommendations.